Urolithin A supplements have moved from obscure research papers to the center of the longevity conversation, promising renewed cellular energy by clearing out worn-out mitochondria. Unlike most trendy compounds, urolithin A has genuine placebo-controlled human trials behind it, though the results are nuanced, dosing matters, and product quality varies widely. This evidence-based guide explains what urolithin A is, what the science actually shows for muscle strength, endurance and healthy aging, how much to take, what the safety data reveals about the liver, and how to choose a quality product worth your money in 2026.
Key Takeaways
- Urolithin A is a postbiotic: a compound your gut bacteria produce from ellagitannins in pomegranates, walnuts and berries. Only an estimated 30 to 40 percent of people convert these foods efficiently.
- Its main mechanism is mitophagy, the cellular recycling process that removes damaged mitochondria and supports ATP energy production.
- Placebo-controlled trials in adults aged 40 to 90 report roughly 10 to 12 percent improvements in lower-body muscle strength and better muscle endurance after four months at 500 to 1,000 mg daily. Some outcomes, including the six-minute walk test in older adults, showed no significant benefit.
- Published trials have not reported clinically significant liver toxicity, and no strong hepatotoxicity signal has emerged, but long-term human data remain limited.
- Studied doses are 500 mg daily for most adults and 1,000 mg daily for adults 65 and older, taken consistently for at least two to four months.
- Independent lab testing has caught underdosed and mislabeled products, so third-party verification matters more than marketing.
- Premium products cost roughly $2 to $3 per day; powders cost less; gummies often deliver less than the studied dose.
- Pregnant or nursing women, anyone under 18, and people taking prescription medications should not use urolithin A without medical guidance.
What Is Urolithin A? A Postbiotic Explained
Urolithin A is a postbiotic: a bioactive compound produced not directly by plants, but by gut bacteria as they digest polyphenols from food. Specifically, it forms when certain microbes break down ellagitannins, tannin-like polyphenols abundant in pomegranates, raspberries, strawberries, blackberries, walnuts and pecans. Bacteria such as Gordonibacter and Ellagibacter species convert ellagitannins into ellagic acid and then into urolithins, with urolithin A being the most studied member of the family.
One misconception deserves immediate attention. Despite the clinical-sounding name, urolithin A is not a drug and has no connection to prescription prostate or urinary medications. It is a naturally occurring metabolite that appears in human blood after ordinary pomegranate or berry consumption.
Supplement makers produce urolithin A through bacterial fermentation, yielding a molecule identical to the one your body makes. This matters because the compound bypasses the gut microbiome entirely. Instead of hoping your resident bacteria perform the conversion, you receive a consistent, measurable dose, which is precisely why researchers could study it in controlled trials.
Scientific interest grew because urolithin A was among the first compounds reported to induce mitophagy in humans, a cellular renewal process described below, with measurable downstream effects on muscle function in randomized trials.
Why Diet Alone Often Is Not Enough: The Conversion Problem
Ellagitannin-rich foods are genuinely healthy. Pomegranate and its juice, raspberries, strawberries, blackberries, walnuts, pecans and chestnuts all feed the gut bacteria that make urolithin A. Eating them regularly supports the gut microbiome in multiple ways beyond this single metabolite.
Here is the catch: not everyone converts them. Research on urolithin metabotypes suggests only about 30 to 40 percent of adults are efficient producers of urolithin A, while the rest generate little or none, regardless of how many pomegranates they eat. This hidden biological variability explains why pomegranate studies produce inconsistent results between individuals and why two people on identical diets can have completely different blood levels of the compound.
Pharmacokinetic research adds a second limitation: dose. A 500 mg urolithin A dose can raise blood concentrations roughly six times higher than a typical glass of pomegranate juice. Juice content itself varies enormously depending on the fruit, processing and storage. Reaching even modest blood levels through food alone is therefore unreliable for most people.
There is currently no routine clinical test that tells you whether you are an efficient converter. You cannot find out your urolithin status from symptoms, and standard blood panels do not measure it. That uncertainty, combined with the conversion problem, is the core argument supplement researchers make for direct supplementation in adults seeking consistent mitochondrial support.
How Urolithin A Works: Mitophagy and Mitochondrial Renewal
Mitochondria are the power plants inside your cells, converting food and oxygen into ATP, the chemical currency of cellular energy. Muscle cells are packed with them, which is why mitochondrial decline shows up first as reduced endurance, slower recovery and creeping fatigue with age.
Damaged mitochondria are more than inefficient; they are harmful. As they degrade, they leak reactive molecules that trigger chronic low-grade inflammation, a process researchers call inflammaging. An aging muscle filled with broken power plants both produces less energy and actively inflames its surroundings.
Urolithin A acts on mitophagy, the cell's quality-control program. Mitophagy works like a recycling service: it identifies dysfunctional mitochondria, breaks them down into components, and clears the way for fresh mitochondria to be built, a process called mitochondrial biogenesis. The result is a younger, higher-functioning mitochondrial network. In preclinical research, this mechanism improved muscle performance, endurance and markers of brain health; in human trials, researchers observed shifts in mitochondrial gene expression and blood biomarkers consistent with improved mitochondrial function.
An important caveat: much of the mechanistic evidence comes from cells, worms and rodents. Human trials measure functional outcomes like strength and walking endurance, and those results, while encouraging, are more modest than early laboratory work suggested.
A practical warning follows from this biology. Symptoms of poor mitochondrial health, such as persistent tiredness, weak grip strength or slow workout recovery, are nonspecific. The same symptoms can stem from poor sleep, low iron, thyroid dysfunction, inadequate vitamin D or magnesium deficiency. Guessing at the root cause risks missing a treatable deficiency. Before attributing fatigue to aging, it is worth covering foundational nutrients your mitochondria rely on daily, including magnesium, and antioxidant nutrients like vitamin C that help manage oxidative stress.
What Human Clinical Trials Actually Show
Urolithin A is one of the few longevity-targeted supplements tested in multiple randomized, placebo-controlled human trials. Most were four months long, used 500 to 1,000 mg daily, and were partly funded by the ingredient manufacturer, which readers should weigh when interpreting uniformly positive framing. The table below summarizes the major published trials.
| Trial | Population | Dose | Duration | Key outcomes |
|---|---|---|---|---|
| First-in-human safety study (D'Amico et al., European Journal of Clinical Nutrition, 2021) | Healthy overweight adults | Up to 1,000 mg | 4 weeks repeated dosing | Well tolerated; dose-dependent blood levels; exploratory improvements in mitochondrial biomarkers and C-reactive protein |
| Sedentary adults trial (Singh et al., Cell Reports Medicine, 2022) | 88 sedentary adults aged 40 to 64 with overweight | 500 mg or 1,000 mg daily | 4 months | Leg muscle strength improved roughly 10 to 12 percent; several endurance measures improved; both doses performed similarly |
| Older adults trial (Liu et al., JAMA Network Open, 2022) | 66 adults aged 65 to 90 with overweight or obesity | 1,000 mg daily | 4 months | No significant improvement in six-minute walk distance, the primary outcome; muscle endurance, mitochondrial gene expression and CRP improved versus placebo |
| 2025 randomized trial on inflammation and immunity | Middle-aged and older adults | Daily urolithin A | Several months | Reduced CRP, an inflammation marker, and favorable shifts in immune cell profiles; findings await replication |
Strength and Endurance Results
The 2022 trial in sedentary adults aged 40 to 64 is the strongest functional result to date. Participants taking 500 or 1,000 mg daily for four months gained roughly 10 to 12 percent in lower-body muscle strength, with measurable improvements in parameters of endurance and exercise performance compared with placebo. Notably, doubling the dose from 500 to 1,000 mg added little, suggesting 500 mg may be sufficient for middle-aged adults.
The Six-Minute Walk Result: An Honest Null Finding
In the trial of adults aged 65 to 90, the primary endpoint, distance covered in the six-minute walk test, did not significantly outperform placebo. Secondary outcomes told a more encouraging story: muscle endurance improved, mitochondrial gene expression shifted favorably, and CRP fell. The honest interpretation is that biomarker improvements do not automatically translate into every functional measure, especially in older adults over only four months. Few supplement companies publicize this null result, but it matters for setting expectations.
Inflammation and Immune Findings
Across several trials, urolithin A reduced CRP inflammation marker levels relative to placebo, aligning with the inflammaging mechanism. A randomized trial published in 2025 extended this by reporting favorable immune cell changes in older adults, an early but intriguing signal that mitochondrial renewal may influence immune function. These findings are promising and still preliminary.
What the Trials Do Not Yet Tell Us
- No study has tested effects beyond roughly six months of continuous use.
- Trials measured healthy or overweight adults, not people with diagnosed mitochondrial or chronic diseases.
- Effects on trained athletes, longevity itself, or hard outcomes like falls and frailty remain unknown.
- Most data involve fermentation-derived urolithin A; results may not transfer to every generic product.
Do Urolithin A Supplements Work? An Honest Verdict
Based on the current evidence, here is a fair reading of urolithin A benefits:
- Reasonably supported: modest improvements in lower-body muscle strength and muscle endurance in sedentary adults over 40, reduced CRP, and favorable mitochondrial biomarkers after four months of 500 to 1,000 mg daily.
- Promising but early: immune cell improvements, exercise recovery benefits, and cognitive or whole-body healthy aging effects.
- Not supported: dramatic fitness gains, weight loss, disease treatment, or guaranteed benefits for everyone; the six-minute walk null result shows functional benefits are not universal.
So, do urolithin A supplements work? For a subset of adults, particularly those over 40 who are sedentary or moderately active, the trial data suggest a real but modest effect on muscle function. Individual response varies, and the effect sizes are smaller than what consistent resistance training delivers. The most defensible position is that urolithin A is a promising, evidence-backed addition to, not a replacement for, exercise and good nutrition.
Urolithin A Dosage: How Much and When to Take It
Human trials used 250 to 1,000 mg per day. For most adults under 65, 500 mg daily is the evidence-aligned dose; the 2022 strength trial found little added benefit at 1,000 mg in that age group. Adults 65 and older, who were studied at 1,000 mg daily, may reasonably choose the higher dose. Effects emerged gradually: biomarker changes appeared within two months, while strength and endurance benefits required about four months of consistent use.
Timing is flexible. Taking urolithin A with a meal containing some fat may support absorption, since the molecule is lipophilic, and consistency matters more than clock time. Morning use alongside breakfast is the most common habit and easiest to sustain.
| Form | Typical dose per serving | Practical notes |
|---|---|---|
| Softgels | 250 to 500 mg | Often suspended in a phospholipid fat matrix; convenient and protects the compound; check whether one or two capsules are needed to reach 500 mg |
| Powder | 500 to 1,000 mg | Flexible dosing and usually the lowest cost per milligram; mixes into drinks; absorption is comparable when taken with food |
| Gummies | 100 to 250 mg | Convenient but typically underdosed relative to trials; often requires multiple pieces; added sugars; check the math carefully |
| Liposomal or combination blends | Varies widely | Delivery claims are rarely independently verified; confirm the urolithin A dose alone still reaches 500 mg |
Head-to-head bioavailability comparisons between formats are limited, so format choice should weigh verified dose, cost per 500 mg, and personal consistency rather than marketing about superior delivery.
Safety, Side Effects, and Liver Concerns
Across published trials involving several hundred participants, doses up to 1,000 mg daily for four to six months were well tolerated. Reported side effects were mild and occurred at rates similar to placebo, mostly transient digestive discomfort and occasional headache. The first-in-human pharmacokinetic study found no safety signals across single doses up to 1,000 mg.
Preclinical toxicology is likewise reassuring. Fermentation-derived urolithin A has received a Generally Recognized as Safe (GRAS) determination, and animal studies using doses many times higher than human equivalents for extended periods did not identify serious adverse effects.
The liver question deserves a direct answer. Is urolithin A hard on the liver? In the clinical trials conducted to date, liver enzymes were monitored and no clinically meaningful elevations were reported. As of early 2026, no published case reports attribute liver injury to urolithin A supplementation, and regulatory safety reviews have not identified hepatotoxicity signals at studied doses. That said, multi-year human data do not exist, and any supplement can pose risk through contamination or mislabeling rather than the active ingredient itself, which is one more reason third-party testing matters. Adults with existing liver disease should consult their physician before use, and anyone who develops dark urine, yellowing of the skin, or unexplained fatigue while supplementing should stop and seek medical evaluation.
A regulatory note for context: urolithin A products are sold as dietary supplements, which the FDA does not evaluate for effectiveness before marketing. This article is educational and is not medical advice.
Who Should Not Take Urolithin A
No trials have included the following groups, so caution is warranted:
- Women who are pregnant or breastfeeding, due to the absence of safety data
- Children and adolescents under 18
- People with liver or kidney disease, unless a physician approves
- Anyone taking prescription medications without first checking with a doctor or pharmacist
On medications specifically: urolithin A is processed through phase II liver pathways, including glucuronidation and sulfation, the same systems that clear many drugs. Formal interaction studies have not been performed. While no problematic interactions have been documented in trials, the honest position is that the data are simply too limited to rule them out, particularly for medications with narrow safety margins.
How to Choose a Quality Urolithin A Supplement
This is where the market gets messy. Because supplements are not pre-approved, what a label claims and what a bottle contains can diverge. Independent laboratory investigations of urolithin A products have flagged items delivering meaningfully less than the labeled amount, and a separate problem involves products sold as urolithin A that actually contain pomegranate extract, meaning ellagitannin precursors your body may never convert, especially if you are one of the majority who are inefficient converters. Verifying that a product contains actual urolithin A, not just precursor extract, is the single most important check.
Use this checklist when comparing the best urolithin A supplement options:
- Match the studied dose. Look for at least 500 mg of urolithin A per serving.
- Confirm the ingredient. The label should list urolithin A itself, not only pomegranate or ellagitannin extract.
- Demand third-party testing. Look for NSF Certified for Sport, USP Verified, Informed Choice, or a publicly available certificate of analysis from an ISO 17025-accredited laboratory matching the lot number on your bottle.
- Check manufacturing standards. cGMP certification and a GRAS-status ingredient indicate baseline quality controls.
- Avoid proprietary blends. If the label hides urolithin A inside a blend, you cannot verify the dose.
- Calculate cost per verified 500 mg. A cheap product at 150 mg per capsule is often the most expensive way to reach an effective dose.
- Prefer transparency. Brands that publish testing methods, sourcing and trial participation are statistically more trustworthy than those that do not.
On the question of Mitopure versus other urolithin A supplements: essentially all published human trials used Mitopure, the patented fermentation-derived ingredient. That does not automatically make brand-name products superior; generic products using the same or equivalent ingredient can perform identically if verified by independent testing. What matters is verified identity, verified dose and verified purity, not the logo on the label.
Urolithin A Combined Formulas: Stacks and Combinations
Because mitochondria depend on multiple inputs, many products pair urolithin A with complementary compounds: CoQ10, an electron transport chain component; resveratrol, a sirtuin-activating polyphenol; betaine (TMG), a methyl donor; alpha-lipoic acid; and NAD+ boosters such as NMN, since NAD+ is required for mitochondrial energy production and sirtuin activity. Liposomal delivery systems are also marketed to enhance absorption.
The evidence picture for these combinations is straightforward: no published randomized trial has tested any urolithin A combination formula. Each partner ingredient carries its own uncertain human evidence base, and liposomal absorption claims for this molecule are largely unverified. Combinations also create a dosing trap, where a blend contains a token 100 or 250 mg of urolithin A alongside several fashionable ingredients, leaving you below the dose that trials actually studied.
A pragmatic approach: if you want a combination product, verify that the urolithin A content alone reaches 500 mg and that other ingredients are dosed at levels with at least plausible human support, such as 100 to 300 mg of CoQ10 or 250 mg or more of NMN. Otherwise, a single-ingredient product at the full evidence-based dose, stacked separately with whatever else you choose, gives you control and transparency.
Urolithin A versus Other Longevity Supplements
If budget is finite, context helps. The comparison below weighs evidence strength, mechanism and typical cost across popular longevity supplements.
| Supplement | Mechanism | Human evidence | Typical daily cost | Bottom line |
|---|---|---|---|---|
| Urolithin A | Mitophagy, mitochondrial renewal | Multiple placebo-controlled trials with modest functional gains | $1.50 to $3.30 | Promising and better tested than most novel options, but premium priced |
| Creatine | Phosphocreatine energy buffer, muscle protein | Large, consistent evidence for strength and lean mass | $0.15 to $0.40 | Highest evidence-to-cost ratio for muscle and aging |
| NMN | NAD+ precursor | Reliably raises NAD+; functional benefits not yet proven | $0.60 to $2.00 | Biomarker first, benefits still pending |
| Resveratrol | Sirtuin activation, antioxidant signaling | Mixed randomized trial results | $0.30 to $1.00 | Inconsistent human record |
| CoQ10 | Electron transport, antioxidant | Modest; best studied in heart failure and statin-related contexts | $0.20 to $0.80 | Situational value, generally safe |
Prioritization matters more than any single bottle. Before spending $30 to $100 monthly on urolithin A, ensure the basics are in place: adequate sleep, resistance and aerobic exercise, sufficient protein, and correction of common shortfalls such as vitamin D, which supports muscle function, or magnesium. A sensible foundational routine may include a well-formulated multivitamin to cover hidden gaps, with urolithin A considered as an advanced add-on once those fundamentals are handled. Readers exploring NAD+ pathways can pair this article with a deeper guide to NMN and NAD+ supplements for a fuller comparison.
Cost Analysis: Is Urolithin A Worth the Money?
No competitor addresses this directly, so here is a neutral breakdown of typical retail pricing as of early 2026. Prices vary with subscriptions and sales.
| Product type | Typical monthly cost | Cost per day | Notes |
|---|---|---|---|
| Premium single-ingredient softgels | $70 to $100 | $2.30 to $3.30 | Brand-name patented ingredient; subscription discounts common |
| Mid-range powders | $45 to $75 | $1.50 to $2.50 | Best cost per verified milligram if third-party tested |
| Gummies | $30 to $50 | $1.00 to $1.70 | Usually half the studied dose; effective daily cost is higher than it appears |
| Combination formulas | $50 to $90 | $1.70 to $3.00 | Value depends entirely on whether each ingredient is dosed meaningfully |
Annualized, premium urolithin A costs roughly $850 to $1,200 per year, compared with about $60 per year for creatine. Whether that represents value depends on your goals and budget. If it displaces essentials like protein, vitamin D or gym access, it is poor spending. If fundamentals are covered and you want evidence-backed mitochondrial support at the margin, the calculus is more defensible. Buying verified powders or tested generics typically halves the cost without sacrificing the dose used in trials.
Who Is a Good Candidate for Urolithin A Supplementation?
Based on trial populations and mechanisms, the profiles most likely to benefit are:
- Adults over 40 noticing declining endurance, slower recovery or reduced leg strength
- Sedentary or lightly active people, the exact populations studied, seeking mitochondrial support while building an exercise habit
- Older adults training to preserve muscle function, where the 1,000 mg dose was studied
- People whose diets rarely include pomegranates, berries or walnuts, and who may be inefficient converters
- Adults with persistent low energy whose medical evaluation, including thyroid, iron, vitamin D and B12 status, has come back normal
Two groups should probably skip it: anyone expecting rapid or dramatic results, and anyone unwilling to commit to at least three to four months of daily use. Because symptoms alone cannot reveal mitochondrial status, treat supplementation as a structured experiment. Record a simple baseline, such as a timed chair-stand test, grip strength or a treadmill or bike endurance benchmark, take the supplement daily for four months, and retest. If nothing measurable improves, the rational choice is to stop and redirect the money. Exercise itself is the most powerful known stimulator of mitophagy, so urolithin A should always sit alongside training, never in place of it.
The Bottom Line
Urolithin A occupies unusual ground in the supplement world: a postbiotic with genuine placebo-controlled human trials, plausible biology, clean short-term safety data and modest but real improvements in muscle strength and endurance for some adults. It also carries premium pricing, incomplete long-term data, one honest null result and a marketplace where independent testing has caught underdosed and mislabeled products. The rational 2026 approach is neither hype nor dismissal. Cover the fundamentals first, verify any product you buy against the checklist above, take an evidence-aligned dose consistently for four months, and judge results by measurable function rather than marketing promises.
Frequently Asked Questions
Do urolithin A supplements work?
Randomized placebo-controlled trials show modest but real improvements in lower-body muscle strength, roughly 10 to 12 percent, and muscle endurance after four months at 500 to 1,000 mg daily, along with reduced CRP inflammation. Not every outcome improved, including the six-minute walk test in older adults, so benefits are best described as consistent for some measures and individual for others.
Is urolithin A hard on the liver?
No. In published clinical trials with enzyme monitoring, clinically significant liver elevations were not reported, and no case reports of liver injury have emerged as of early 2026. Animal toxicology at doses far above human levels found no liver harm, though multi-year human data remain unavailable.
Who should not take urolithin A?
Pregnant or nursing women, children under 18, and people with liver or kidney disease should avoid it or seek medical approval first. Anyone taking prescription medications should consult a doctor or pharmacist because formal interaction studies have not been conducted.
What is the best form of urolithin A supplement: softgel, powder, gummy or liposomal?
Softgels and powders are the most practical because they reliably deliver the studied 500 to 1,000 mg dose, and powders usually cost less per milligram. Gummies are typically underdosed, and liposomal delivery claims lack independent verification. Format matters less than verified dose and third-party testing.
How long does it take to see results from urolithin A supplements?
Mitochondrial biomarkers shift within about two months, while strength and endurance benefits in trials emerged after four months of daily use. Plan on at least a three to four month commitment with objective before-and-after measures.
Can you get enough urolithin A from pomegranates and other foods alone?
Probably not consistently. Only about 30 to 40 percent of people convert ellagitannins efficiently, and a 500 mg supplement raises blood levels roughly six times higher than a glass of pomegranate juice. Foods remain valuable for overall health, but they are an unreliable source of this specific metabolite.
What dose of urolithin A was used in human clinical trials?
Trials used 250 to 1,000 mg daily, with 500 mg as the standard dose in middle-aged adults and 1,000 mg in adults aged 65 to 90. Doubling from 500 to 1,000 mg added little in middle-aged participants.
Can urolithin A be combined with NMN, resveratrol or creatine?
No harmful interactions have been documented, and the mechanisms are complementary, though no trial has tested these stacks together. Creatine in particular is well matched for muscle aging. Verify each ingredient is dosed individually rather than relying on underdosed combination blends.
Is urolithin A safe for long-term use?
Trials up to six months show good tolerability, and toxicology studies support a wide safety margin, but data beyond six months of continuous human use do not yet exist. A periodic reassessment, or a break to evaluate whether it is still providing value, is a reasonable strategy.
Can urolithin A replace exercise?
No. Exercise remains the most potent stimulator of mitophagy and delivers far larger effects on muscle, cardiovascular and metabolic health than any supplement. Urolithin A is best viewed as a complement that may amplify, not substitute for, training.
Should I cycle urolithin A?
There is no evidence that cycling is necessary, and all trials used continuous daily dosing. If you prefer to cycle, evaluate effects with objective measures during on-periods so the decision is based on data rather than habit.
How do I verify a product actually contains what the label claims?
Look for a current certificate of analysis from an ISO 17025-accredited lab matching your lot number, or third-party certification such as NSF, USP or Informed Choice. Also confirm the label lists urolithin A itself rather than pomegranate extract, which many converters cannot turn into meaningful blood levels.
Selected References
- D'Amico D, et al. Safety and pharmacokinetics of urolithin A in healthy overweight adults: first-in-human trial. European Journal of Clinical Nutrition, 2021.
- Singh A, et al. Urolithin A improves muscle strength, mitochondrial health and markers of exercise performance in sedentary adults: randomized placebo-controlled trial. Cell Reports Medicine, 2022.
- Liu S, et al. Effect of urolithin A supplementation on muscle endurance and mitochondrial health in older adults: randomized clinical trial. JAMA Network Open, 2022.
- Andreux PA, et al. Mitochondrial and immune responses to urolithin A supplementation in older adults. Cell Reports, 2019.
- Randomized placebo-controlled trial of urolithin A reporting reduced C-reactive protein and favorable immune cell profiles in older adults, 2025.
Keywords: urolithin a supplements, best urolithin a supplement, urolithin a benefits, urolithin a dosage, mitopure vs other urolithin a supplements, mitophagy, mitochondrial health, postbiotic, ellagitannins, pomegranate, walnuts, gut microbiome, cellular energy, ATP energy production, muscle strength, endurance, healthy aging, longevity supplements, inflammaging, CRP inflammation marker, mitochondrial biogenesis, NAD+, NMN, resveratrol, CoQ10, liposomal delivery, NSF Certified for Sport, FDA GRAS, third-party lab testing, placebo-controlled trials, six-minute walk test, supplement quality, urolithin a side effects, urolithin a liver safety, who should not take urolithin a
